A - Agilent Technologies, Inc.
| Previous Close | 90.13 |
| Open | 89.62 |
| Bid | 0.00 x 900 |
| Ask | 89.30 x 800 |
| Day's Range | 88.66 - 89.98 |
| 52 Week Range | 65.35 - 90.64 |
| Volume | 1,100,220 |
| Avg. Volume | 1,627,620 |
| Market Cap | 27.628B |
| Beta (5Y Monthly) | 1.43 |
| PE Ratio (TTM) | 26.43 |
| EPS (TTM) | 3.37 |
| Earnings Date | Feb 17, 2020 |
| Forward Dividend & Yield | 0.72 (0.81%) |
| Ex-Dividend Date | Dec 28, 2019 |
| 1y Target Est | 88.81 |
- American City Business Journals
Former CEO claims Youngsville firm's founder is trying to cut him out of a buyout bonus
A former CEO is suing a Youngsville company, claiming it – and its founder – are trying to cut him out of his share of a possible buyout.
- Business Wire
Agilent Announces CrossLab Group Leadership Transition
Agilent announces CrossLab Group leadership transition; Mark Doak to retire May 1. Padraig McDonnell selected as his replacement.
- Business Wire
Agilent Wins Multiple Innovation Awards
Agilent Technologies Inc. (NYSE: A) today announced that both The Analytical Scientist and The Medicine Maker have honored the Agilent InfinityLab LC/MSD iQ system with 2019 Innovation Awards.
- Business Wire
Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema
Agilent Technologies Inc. (NYSE: A) is collaborating with researchers at two UK universities who are looking into the risk factors for atopic eczema (also known as atopic dermatitis), a chronic skin condition that affects one in five children and one in 12 adults.
- GuruFocus.com
Parnassus Endeavor Fund Adds to Cisco, Alphabet
Fund's largest buys of the 4th quarter Continue reading...
- GuruFocus.com
Parnassus Endeavor Fund Invests in Insurance and Logistics in 4th Quarter
Socially responsible fund adds Progressive, Expeditors International to portfolio Continue reading...
- Simply Wall St.
Agilent Technologies, Inc. (NYSE:A) Delivered A Better ROE Than Its Industry
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
- Zacks
Timing the Market, Is it Possible? - January 10, 2020
In the long-run, does consistent market timing really matter to be a successful investor?
- Barrons.com
Bill Ackman’s Fund Gained 58% Last Year. Why It Looks Like a Buy.
Pershing Square Holdings’ 2019 performance topped virtually all U.S. mutual funds and beat the S&P 500, which returned 31.5% including dividends. But it’s trading at a 28% discount to its net asset value.
- Business Wire
Agilent Expands Cross-Vendor CDS Instrument Control
Agilent Technologies Inc. (NYSE: A) today announced the latest implementation of its mutual compatibility philosophy. Now, joint customers of Agilent Technologies and Thermo Fisher Scientific can choose a chromatography data system from either company—Agilent OpenLab CDS or Thermo Fisher Chromeleon—to control analytical instruments from both organizations.
- GuruFocus.com
Urbem's 'Wonderful Business' Series: Waters
An installed-base business driven by organic innovation and multiple tailwinds Continue reading...
- Business Wire
Agilent Compliance Services Voted No. 1 in Global Survey
Agilent Technologies Inc. (NYSE: A) today announced that the company’s ability to help laboratories comply with government regulations has been ranked second to none in a global survey.
- Morningstar
Agilent's Wide Moat Remains Intact
- Insider Monkey
How Did Agilent Technologies Inc. (A) Compare Against Top Hedge Fund Stocks in 2019?
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and deteriorating expectations towards the resolution of the trade war with China, many smart money investors kept their cautious approach regarding the current bull run in the third quarter and hedging or reducing many of […]
- Zacks
Why Is Agilent (A) Up 5.4% Since Last Earnings Report?
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Simply Wall St.
Agilent Technologies, Inc. Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Last week saw the newest full-year earnings release from Agilent Technologies, Inc. (NYSE:A), an important milestone...
- Barrons.com
Pershing Square Takes Stake in Agilent. Plus Resideo, Rocket Pharma, and 9 Other 13D Filings
Securities and Exchange Commission filings on Resideo, Rocket Pharma, GTT, and eight other companies
- Simply Wall St.
Do You Know What Agilent Technologies, Inc.'s (NYSE:A) P/E Ratio Means?
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). To keep it...
- Business Wire
Agilent Technologies to Present at J.P. Morgan Healthcare Conference
Agilent to present at 38th Annual J. P. Morgan Healthcare Conference
- Zacks
The Market Timing Secrets No One Talks About - December 17, 2019
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
- Benzinga
There's A New Trading Tool That Allows Traders To Trade Cannabis With Leverage
U.S. traders looking to actively trade cannabis stocks have a new instrument to use in their trading toolkit. REX Shares, a Connecticut-based provider of exchange-traded products, announced today the launch of the MicroSectors Cannabis 2x Leveraged ETN (MJO), the first U.S.-listed leveraged cannabis product. “There is a void in the market for trading products around cannabis,” said Scott Acheychek, president of REX Shares.
- Benzinga
PreMarket Prep Recap: Yo-Yo Market And After-Hours Overshoot On Ackman's New Stake
The weakness from the end of Monday's session had follow through in the overnight session and had market participants preparing for a red day, until it was rumored the Dec. 15 tariffs on China were going to be delayed. Just after the close on Monday, it was announced Bill Ackman's Pershing Square amended 13F filing revealed a 2.916 million share stake in Agilent Technologies (NYSE: A).
- GuruFocus.com
Bill Ackman's Pershing Square Packs Into Agilent
Activist firm discloses new holding in medical device company Continue reading...
- Barrons.com
Bill Ackman’s Pershing Square Capital Bought Up Agilent Stock
The hedge fund owned nearly 3 million shares of the life-sciences company at the end of the third quarter. Agilent stock is beating the S&P 500 so far in the fourth quarter.
- Barrons.com
Stock in Stitch Fix and Agilent Is Gaining as Worry Over Tariffs Drags on the Dow
The main U.S. stock indexes were lower as investors awaited signs of progress on trade ahead of Sunday, when new tariffs on imports from China are to take effect.
